0.75
Precedente Chiudi:
$0.7794
Aprire:
$0.783
Volume 24 ore:
2.82M
Relative Volume:
2.00
Capitalizzazione di mercato:
$62.44M
Reddito:
$24.99M
Utile/perdita netta:
$-118.64M
Rapporto P/E:
-0.5725
EPS:
-1.31
Flusso di cassa netto:
$-100.25M
1 W Prestazione:
-15.73%
1M Prestazione:
-7.43%
6M Prestazione:
+13.28%
1 anno Prestazione:
-41.41%
Adicet Bio Inc Stock (ACET) Company Profile
Nome
Adicet Bio Inc
Settore
Industria
Telefono
617-482-2333
Indirizzo
131 DARTMOUTH STREET, BOSTON
Confronta ACET con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ACET
Adicet Bio Inc
|
0.75 | 119.45M | 24.99M | -118.64M | -100.25M | -1.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-30 | Ripresa | Guggenheim | Buy |
| 2024-09-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-06-27 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-06-27 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-06-01 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-09-21 | Iniziato | JP Morgan | Overweight |
| 2022-03-31 | Iniziato | SMBC Nikko | Outperform |
| 2022-03-08 | Iniziato | Truist | Buy |
| 2022-03-04 | Iniziato | Jefferies | Buy |
| 2021-05-18 | Iniziato | BTIG Research | Buy |
| 2021-04-23 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-14 | Iniziato | Canaccord Genuity | Buy |
| 2021-04-08 | Iniziato | Guggenheim | Buy |
| 2020-11-04 | Iniziato | B. Riley Securities | Buy |
| 2020-10-27 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-10-16 | Iniziato | Wedbush | Outperform |
Mostra tutto
Adicet Bio Inc Borsa (ACET) Ultime notizie
Risk adjusted return profile for Adicet Bio Inc. analyzed2025 Top Decliners & Intraday High Probability Alerts - newser.com
How analysts revise price targets for Adicet Bio Inc. (1IJA) stock2025 Investor Takeaways & Consistent Growth Stock Picks - newser.com
Will Adicet Bio Inc. stock benefit from green energy trends2025 Geopolitical Influence & Consistent Growth Equity Picks - newser.com
Adicet Bio (NASDAQ:ACET) Shares Cross Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Adicet Bio Inc 1IJA Stock Analysis and ForecastTechnical Analysis Insights & Free Real-Time Trading Signals - earlytimes.in
How supply chain issues affect Adicet Bio Inc. stockDay Trade & AI Enhanced Trading Signals - newser.com
Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update - MarketBeat
Can Adicet Bio Inc. stock outperform in 2025 bull marketOil Prices & Detailed Earnings Play Strategies - newser.com
Can Adicet Bio Inc. stock maintain growth trajectory2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com
Can trapped investors hope for a rebound in Adicet Bio Inc.Market Rally & Reliable Breakout Forecasts - newser.com
How Adicet Bio Inc. stock valuations compare to rivalsJuly 2025 Spike Watch & Weekly Chart Analysis and Trade Guides - newser.com
Will Adicet Bio Inc. stock return to pre crisis levelsTrade Entry Report & High Accuracy Trade Alerts - newser.com
How strong is Adicet Bio Inc. stock revenue growth2025 Fundamental Recap & AI Driven Stock Reports - newser.com
Why Adicet Bio Inc. (1IJA) stock could rally stronglyMarket Activity Recap & Stepwise Entry and Exit Trade Signals - newser.com
Adicet Bio reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
Adicet Bio (Nasdaq: ACET) grants options for 97,200 shares and four-year vesting - Stock Titan
Adicet Bio (NASDAQ:ACET) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Why Adicet Bio Inc. (1IJA) stock remains top ratedJuly 2025 Rallies & Real-Time Volume Spike Alerts - newser.com
Can Adicet Bio Inc. stock beat market expectations this quarterTrade Entry Summary & Reliable Volume Spike Trade Alerts - newser.com
Historical volatility pattern of Adicet Bio Inc. visualizedWeekly Market Report & Advanced Swing Trade Entry Plans - newser.com
Price momentum metrics for Adicet Bio Inc. explainedMarket Growth Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Can Adicet Bio Inc. (1IJA) stock double in coming yearsJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
Adicet Bio (ACET) Expected to Announce Earnings on Wednesday - MarketBeat
How Adicet Bio Inc. stock reacts to oil pricesWeekly Volume Report & Weekly High Conviction Ideas - newser.com
How Adicet Bio Inc. (1IJA) stock valuation compares with sectorAnalyst Upgrade & Technical Pattern Based Signals - newser.com
How institutional ownership impacts Adicet Bio Inc. stockIndex Update & AI Driven Price Forecasts - newser.com
What drives Adicet Bio Inc stock priceMarket Breadth Indicators & Minimal Risk High Reward - earlytimes.in
Adicet Bio, Inc. (NASDAQ:ACET) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Adicet Bio Inc Azioni (ACET) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):